This includes, but is not limited to: cardiac arrhythmia, high or low blood pressure, heart, liver, kidney or thyroid disease, recurrent headaches, seizure disorder, anxiety, depression, psychiatric or epileptic disorders, diabetes, pernicious anemia, difficulty urinating, enlarged prostate, glaucoma or if you are taking a MAO inhibitor, anti-depressants, aspirin, non-steroidal anti-inflammatory drugs or products containing ephedrine, pseudoephedrine or other medications or over the counter drugs containing stimulants or any other medication
Nat Immunol (2001) 2:10815
If you have severe symptoms such as confusion, passing out, and or seizures, call 911
It seems that serum carnitine levels decrease in individuals with obesity and metabolic syndrome due to insulin resistance, therefore supplement therapy with L-carnitine can help improve glycemic status by reducing insulin resistance (104)
But their real power lies in using them strategically , not continuously
Beyond the obesity indication, they are studying retatrutide for type 2 diabetes (TRIUMPH-2), obstructive sleep apnea (TRIUMPH-3), and cardiovascular outcomes
